OptiBiotix Health has launched OptiXOS, a new xylooligosaccharide (XOS) prebiotic, slated for both European and African Markets. The ingredient has been tested in clinical trials and has shown an ability to increase positive gut health microbes at low active doses, according to the company. It also has good stability at high temperature, a low pH, and less gas than other prebiotics. 

www.optibiotix.com